ESR1 and breast cancer: Selective ERβ Agonists Exert Anti-Proliferative and Proapoptotic Effects on ERα+ Breast Cancer Cell Lines and Results in Increased Expression of FOXO 1/3 Proteins in ERα+ Breast Cancer Cell Lines